1. Home
  2. STOK vs BJRI Comparison

STOK vs BJRI Comparison

Compare STOK & BJRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STOK
  • BJRI
  • Stock Information
  • Founded
  • STOK 2014
  • BJRI 1978
  • Country
  • STOK United States
  • BJRI United States
  • Employees
  • STOK N/A
  • BJRI N/A
  • Industry
  • STOK Biotechnology: Pharmaceutical Preparations
  • BJRI Restaurants
  • Sector
  • STOK Health Care
  • BJRI Consumer Discretionary
  • Exchange
  • STOK Nasdaq
  • BJRI Nasdaq
  • Market Cap
  • STOK 721.4M
  • BJRI 837.4M
  • IPO Year
  • STOK 2019
  • BJRI 1996
  • Fundamental
  • Price
  • STOK $11.67
  • BJRI $37.03
  • Analyst Decision
  • STOK Strong Buy
  • BJRI Hold
  • Analyst Count
  • STOK 7
  • BJRI 7
  • Target Price
  • STOK $21.40
  • BJRI $37.50
  • AVG Volume (30 Days)
  • STOK 562.4K
  • BJRI 228.4K
  • Earning Date
  • STOK 11-05-2024
  • BJRI 02-13-2025
  • Dividend Yield
  • STOK N/A
  • BJRI N/A
  • EPS Growth
  • STOK N/A
  • BJRI 95.73
  • EPS
  • STOK N/A
  • BJRI 1.26
  • Revenue
  • STOK $16,742,999.00
  • BJRI $1,336,598,000.00
  • Revenue This Year
  • STOK $103.04
  • BJRI $3.13
  • Revenue Next Year
  • STOK N/A
  • BJRI $3.35
  • P/E Ratio
  • STOK N/A
  • BJRI $29.34
  • Revenue Growth
  • STOK 81.08
  • BJRI N/A
  • 52 Week Low
  • STOK $4.09
  • BJRI $27.61
  • 52 Week High
  • STOK $17.58
  • BJRI $38.87
  • Technical
  • Relative Strength Index (RSI)
  • STOK 41.75
  • BJRI 56.82
  • Support Level
  • STOK $11.80
  • BJRI $35.43
  • Resistance Level
  • STOK $12.58
  • BJRI $38.27
  • Average True Range (ATR)
  • STOK 0.83
  • BJRI 1.27
  • MACD
  • STOK -0.06
  • BJRI 0.02
  • Stochastic Oscillator
  • STOK 8.32
  • BJRI 64.82

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is engaged in addressing the underlying causes of severe diseases by upregulating protein expression with RNA-based medicines. Using its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, it is developing antisense oligonucleotides (ASOs) to selectively restore protein levels. Its first compound, STK-001, is in clinical testing for the treatment of Dravet syndrome, a severe and progressive genetic epilepsy. The company primarily operates in the U.S.

About BJRI BJ's Restaurants Inc.

BJ's Restaurants Inc is involved in the business of owning and operating restaurants. The company operates in one operating segment that is casual dining company-owned restaurants. It has geographic presence only in the United States of America.

Share on Social Networks: